{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:32:46Z","timestamp":1793302366514,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012205"],"award-info":[{"award-number":["2024A1515012205"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010141"],"award-info":[{"award-number":["2023A1515010141"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1515230011"],"award-info":[{"award-number":["2021B1515230011"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of President of Zhujiang hospita","id":[{"id":"https:\/\/ror.org\/02mhxa927","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key-Area Research and Development Program of Guangdong Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite the advancements in treatment strategies, the long-term survival of hepatocellular carcinoma (HCC) is still pessimistic. Therefore, understanding the mechanisms of hepatocellular carcinoma may offer substantial benefits for patients. Our previous research has revealed that Hornerin promoted HCC progression by regulating the AKT signaling pathway. To investigate the upstream regulatory mechanism, the results from RNA Immunoprecipitation and RNA pull-down indicated that the specific region of circIPP2A2 interacted with Hornerin. Additionally, patients with circIPP2A2 upregulation exhibited a poorer survival outcome following surgery compared to the cases with downregulated circIPP2A2. After the structure verification of circIPP2A2, loss-of-function studies using a lentiviral vector revealed that circIPP2A2 downregulation significantly inhibited HCC tumorigenesis and progression both in vitro and in vivo. Mechanistically, the m7G-MeRIP results demonstrated significant enrichment of circIPP2A2. Subsequent studies validated that METTL1 influenced the stability of circIPP2A2 and its binding affinity with Hornerin. Immunoprecipitation and immunofluorescence indicated that circIPP2A2 served as a molecular scaffold to facilitate Hornerin to interact with PI3K. In conclusion, our findings reveal that circIPP2A2, regulated by N7-methylguanosine modification, promotes malignant behaviors in HCC by serving as a molecular scaffold in modulating the Hornerin\/PI3K\/AKT\/GSK3\u03b2 axis. Targeting circIPP2A2 may be a promising therapeutic strategy for patients with HCC.<\/jats:p>","DOI":"10.1038\/s41419-024-07248-7","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T04:30:01Z","timestamp":1732941001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin\/PI3K\/AKT\/GSK3\u03b2 axis"],"prefix":"10.1038","volume":"15","author":[{"given":"Zeyi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxiang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-5908","authenticated-orcid":false,"given":"Shunjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"7248_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7248_CR2","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1136\/gutjnl-2023-330691","volume":"72","author":"Z Liu","year":"2023","unstructured":"Liu Z, Lin C, Mao X, Guo C, Suo C, Zhu D, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023;72:2354\u201363.","journal-title":"Gut"},{"key":"7248_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention, and therapy. Nat Rev Clin Oncol. 2023;20:864\u201384.","journal-title":"Nat Rev Clin Oncol"},{"key":"7248_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten TF, Villanueva A, Korangy F, Ruf B, Yarchoan M, Ma L, et al. Biomarkers for immunotherapy of hepatocellular carcinoma. Nat Rev Clin Oncol. 2023;20:780\u201398.","journal-title":"Nat Rev Clin Oncol"},{"key":"7248_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7248_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","volume":"41","author":"R Chen","year":"2023","unstructured":"Chen R, Wang SK, Belk JA, Amaya L, Li Z, Cardenas A, et al. Engineering circular RNA for enhanced protein production. Nat Biotechnol. 2023;41:262\u201372.","journal-title":"Nat Biotechnol"},{"key":"7248_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","volume":"76","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wang H, Li Z, Li F, Liang L, Zou Y, et al. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol. 2022;76:135\u201347.","journal-title":"J Hepatol"},{"key":"7248_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/0008-5472.CAN-21-1628","volume":"82","author":"Y Chen","year":"2022","unstructured":"Chen Y, Ling Z, Cai X, Xu Y, Lv Z, Man D, et al. Activation of YAP1 by N6-methyladenosine-modified circCPSF6 drives malignancy in hepatocellular carcinoma. Cancer Res. 2022;82:599\u2013614.","journal-title":"Cancer Res"},{"key":"7248_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.tcb.2022.07.001","volume":"32","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lin H, Miao L, He J. Role of N7-methylguanosine (m7G) in cancer. Trends Cell Biol. 2022;32:819\u201324.","journal-title":"Trends Cell Biol"},{"key":"7248_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-022-05565-5","volume":"613","author":"VM Ruiz-Arroyo","year":"2023","unstructured":"Ruiz-Arroyo VM, Raj R, Babu K, Onolbaatar O, Roberts PH, Nam Y. Structures and mechanisms of tRNA methylation by METTL1\u2013WDR4. Nature. 2023;613:383\u201390.","journal-title":"Nature"},{"key":"7248_CR11","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.molcel.2019.03.040","volume":"74","author":"L Pandolfini","year":"2019","unstructured":"Pandolfini L, Barbieri I, Bannister AJ, Hendrick A, Andrews B, Webster N, et al. METTL1 promotes let-7 microRNA processing via m7G methylation. Mol Cell. 2019;74:1278\u201390.e9.","journal-title":"Mol Cell"},{"key":"7248_CR12","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.molcel.2021.07.003","volume":"81","author":"Z Dai","year":"2021","unstructured":"Dai Z, Liu H, Liao J, Huang C, Ren X, Zhu W, et al. N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Mol Cell. 2021;81:3339\u201355.e8.","journal-title":"Mol Cell"},{"key":"7248_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4719-5","volume":"18","author":"SJ Fu","year":"2018","unstructured":"Fu SJ, Shen SL, Li SQ, Hua YP, Hu WJ, Guo B, et al. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma. BMC Cancer. 2018;18:815.","journal-title":"BMC Cancer"},{"key":"7248_CR14","doi-asserted-by":"publisher","first-page":"W72","DOI":"10.1093\/nar\/gkab393","volume":"49","author":"A Armaos","year":"2021","unstructured":"Armaos A, Colantoni A, Proietti G, Rupert J, Tartaglia GG. catRAPID omics v2.0: going deeper and wider in the prediction of protein-RNA interactions. Nucleic Acids Res. 2021;49:W72\u20139.","journal-title":"Nucleic Acids Res"},{"key":"7248_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02018-y","volume":"21","author":"W Wu","year":"2020","unstructured":"Wu W, Ji P, Zhao F. CircAtlas: an integrated resource of one million highly accurate circular RNAs from 1070 vertebrate transcriptomes. Genome Biol. 2020;21:101.","journal-title":"Genome Biol"},{"key":"7248_CR16","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"7248_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.omtn.2019.08.022","volume":"18","author":"W Chen","year":"2019","unstructured":"Chen W, Feng P, Song X, Lv H, Lin H. iRNA-m7G: identifying N7-methylguanosine sites by fusing multiple features. Mol Ther Nucleic Acids. 2019;18:269\u201374.","journal-title":"Mol Ther Nucleic Acids"},{"key":"7248_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s13402-023-00814-9","volume":"46","author":"Z Guo","year":"2023","unstructured":"Guo Z, Xie Q, Wu Y, Mo H, Zhang J, He G, et al. Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B\/RAS\/MAPK axis in hepatocellular carcinoma. Cell Oncol. 2023;46:1333\u201350.","journal-title":"Cell Oncol"},{"key":"7248_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-022-01285-5","volume":"15","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yao Y, Wu P, Zi X, Sun N, He J. The potential role of N7-methylguanosine (m7G) in cancer. J Hematol Oncol. 2022;15:63.","journal-title":"J Hematol Oncol"},{"key":"7248_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41586-022-05566-4","volume":"613","author":"J Li","year":"2023","unstructured":"Li J, Wang L, Hahn Q, Nowak RP, Viennet T, Orellana EA, et al. Structural basis of regulated m7G tRNA modification by METTL1\u2013WDR4. Nature. 2023;613:391\u20137.","journal-title":"Nature"},{"key":"7248_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","volume":"157","author":"TR Cech","year":"2014","unstructured":"Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014;157:77\u201394.","journal-title":"Cell"},{"key":"7248_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179:1033\u201355.","journal-title":"Cell"},{"key":"7248_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19:188\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"key":"7248_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ymthe.2021.08.026","volume":"30","author":"Y Li","year":"2022","unstructured":"Li Y, Wang Z, Su P, Liang Y, Li Z, Zhang H, et al. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt\/beta-catenin pathway. Mol Ther. 2022;30:415\u201330.","journal-title":"Mol Ther"},{"key":"7248_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ebiom.2019.08.074","volume":"48","author":"D Yan","year":"2019","unstructured":"Yan D, Dong W, He Q, Yang M, Huang L, Kong J, et al. Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation. EBioMedicine. 2019;48:316\u201331.","journal-title":"EBioMedicine"},{"key":"7248_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/0008-5472.CAN-21-1473","volume":"82","author":"AA Ishola","year":"2022","unstructured":"Ishola AA, Chien CS, Yang YP, Chien Y, Yarmishyn AA, Tsai PH, et al. Oncogenic circRNA C190 promotes non-small cell lung cancer via modulation of the EGFR\/ERK pathway. Cancer Res. 2022;82:75\u201389.","journal-title":"Cancer Res"},{"key":"7248_CR27","doi-asserted-by":"publisher","first-page":"47445","DOI":"10.1074\/jbc.M107512200","volume":"276","author":"T Makino","year":"2001","unstructured":"Makino T, Takaishi M, Morohashi M, Huh NH. Hornerin, a novel profilaggrin-like protein and differentiation-specific marker isolated from mouse skin. J Biol Chem. 2001;276:47445\u201352.","journal-title":"J Biol Chem"},{"key":"7248_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-266","volume":"12","author":"JM Fleming","year":"2012","unstructured":"Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK. Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer. BMC Cancer. 2012;12:266.","journal-title":"BMC Cancer"},{"key":"7248_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00488-6","volume":"8","author":"MF Gutknecht","year":"2017","unstructured":"Gutknecht MF, Seaman ME, Ning B, Cornejo DA, Mugler E, Antkowiak PF, et al. Identification of the S100 fused-type protein Hornerin as a regulator of tumor vascularity. Nat Commun. 2017;8:552.","journal-title":"Nat Commun"},{"key":"7248_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150:12\u201327.","journal-title":"Cell"},{"key":"7248_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener D, Schwartz S. The epitranscriptome beyond m6A. Nat Rev Genet. 2021;22:119\u201331.","journal-title":"Nat Rev Genet"},{"key":"7248_CR32","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.cell.2023.05.047","volume":"186","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Qing Y, Dong L, Han L, Wu D, Li Y, et al. QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023;186:3208\u201326.e27.","journal-title":"Cell"},{"key":"7248_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605\u201335.","journal-title":"Cell"},{"key":"7248_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"F Vara","year":"2004","unstructured":"Vara F, Casado JA, de Castro E, Cejas J, Belda-Iniesta P, Gonz\u00e1lez-Bar\u00f3n C. M. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30:193\u2013204.","journal-title":"Cancer Treat Rev"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07248-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07248-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07248-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T05:03:37Z","timestamp":1732943017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07248-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["7248"],"URL":"https:\/\/doi.org\/10.1038\/s41419-024-07248-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethical committee of Zhujiang Hospital and Sun Yat-sen University Cancer Center. Informed consent was obtained from all patients. The animal experimental protocols were approved by the Animal Ethics Committee of Zhujiang Hospital (LAEC-2023-031). All methods were carried out in accordance with the relevant ethical guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"868"}}